HRMY
Harmony Biosciences Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$42.25
+0.93%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+30.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| May 18, 2026 | Graf R. Mark · director | A-Award | 21,872 | $31 |
| May 18, 2026 | Sender Gary · director | A-Award | 21,872 | $31 |
| May 18, 2026 | Philip Ron M · director | A-Award | 21,872 | $31 |
| May 18, 2026 | Sabater Juan A. · director | A-Award | 21,872 | $31 |
| May 18, 2026 | Budur Kumar · officer: CHIEF MEDICAL OFFICER | M-Exempt | 18,750 | $0.00 |
| May 18, 2026 | Budur Kumar · officer: CHIEF MEDICAL OFFICER | F-InKind | 8,882 | $32 |
| May 18, 2026 | Reicin Glenn · officer: CHIEF FINANCIAL OFFICER | A-Award | 164,309 | $29 |
| May 18, 2026 | Germano Geno J · director | A-Award | 21,231 | $31 |
| May 18, 2026 | Szyper Linda M · director | A-Award | 21,872 | $31 |
| Apr 9, 2026 | Zaeske Adam H. · officer: CHIEF COMMERCIAL OFFICER | M-Exempt | 7,500 | $0.00 |
| Apr 9, 2026 | Zaeske Adam H. · officer: CHIEF COMMERCIAL OFFICER | F-InKind | 3,173 | $28 |
| Apr 6, 2026 | Anastasiou Peter · officer: CHIEF OPERATING OFFICER | A-Award | 212,241 | $28 |
| Apr 6, 2026 | Ignelzi Troy A. · director | A-Award | 17,710 | $28 |
| Jan 28, 2026 | Kapadia Sandip · officer: CHIEF FINANCIAL OFFICER | Sale | 3,746 | $37 |
| Jan 26, 2026 | Budur Kumar · officer: CHIEF MEDICAL OFFICER | F-InKind | 1,372 | $37 |
| Jan 26, 2026 | Budur Kumar · officer: CHIEF MEDICAL OFFICER | F-InKind | 1,153 | $37 |
| Jan 26, 2026 | Zaeske Adam H. · officer: CHIEF COMMERCIAL OFFICER | A-Award | 56,900 | $37 |
| Jan 26, 2026 | Zaeske Adam H. · officer: CHIEF COMMERCIAL OFFICER | A-Award | 16,200 | $0.00 |
| Jan 26, 2026 | Dayno Jeffrey M. · director, officer: PRESIDENT, CEO | A-Award | 184,600 | $37 |
| Jan 26, 2026 | Dayno Jeffrey M. · director, officer: PRESIDENT, CEO | A-Award | 52,900 | $0.00 |
| Jan 26, 2026 | Dayno Jeffrey M. · director, officer: PRESIDENT, CEO | M-Exempt | 13,000 | $0.00 |
| Jan 26, 2026 | Dayno Jeffrey M. · director, officer: PRESIDENT, CEO | M-Exempt | 10,500 | $0.00 |
| Jan 26, 2026 | Dayno Jeffrey M. · director, officer: PRESIDENT, CEO | F-InKind | 5,654 | $37 |
| Jan 26, 2026 | Dayno Jeffrey M. · director, officer: PRESIDENT, CEO | F-InKind | 4,785 | $37 |
| Jan 26, 2026 | Budur Kumar · officer: CHIEF MEDICAL OFFICER | M-Exempt | 2,188 | $0.00 |
| Jan 26, 2026 | Kapadia Sandip · officer: CHIEF FINANCIAL OFFICER | A-Award | 12,200 | $0.00 |
| Jan 26, 2026 | Kapadia Sandip · officer: CHIEF FINANCIAL OFFICER | M-Exempt | 3,813 | $0.00 |
| Jan 26, 2026 | Kapadia Sandip · officer: CHIEF FINANCIAL OFFICER | F-InKind | 2,553 | $37 |
| Jan 26, 2026 | Kapadia Sandip · officer: CHIEF FINANCIAL OFFICER | F-InKind | 2,239 | $37 |
| Jan 26, 2026 | Serafin Andrew · officer: CHIEF STRATEGY OFFICER | A-Award | 42,600 | $37 |
Institutional positioning
13F filings over the trailing two quarters
New 97Increased 264Reduced 210Sold out 35
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 7,101,965 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 7,070,035 | May 13, 2026 |
| FMR LLC | Increased | 3,574,115 | Aug 13, 2026 |
| FMR LLC | Increased | 3,157,639 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 2,880,489 | Aug 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 2,714,353 | May 8, 2026 |
| AMERICAN CENTURY COMPANIES INC | Increased | 2,539,512 | Aug 12, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Increased | 2,393,588 | Aug 11, 2026 |
| AMERICAN CENTURY COMPANIES INC | Increased | 2,105,179 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 2,105,053 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,102,315 | May 15, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Increased | 2,076,510 | May 7, 2026 |
| LSV ASSET MANAGEMENT | Increased | 2,061,242 | Aug 6, 2026 |
| LSV ASSET MANAGEMENT | Increased | 2,025,143 | May 11, 2026 |
| SG AMERICAS SECURITIES, LLC | Increased | 2,018,174 | Apr 16, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing May 18, 2026